Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 2/2019

01-04-2019 | Case Report

An intensive medical care network led to successful living-donor liver transplantation in late-onset hepatic failure with disseminated Staphylococcus aureus infection

Published in: Clinical Journal of Gastroenterology | Issue 2/2019

Login to get access

Abstract

Here, we describe a 42-year-old male patient with late-onset hepatic failure (LOHF) due to acute-onset autoimmune hepatitis. At first, his response to steroid therapy was good, but hepatitis relapsed during steroid pulse therapy. Deterioration of liver function caused LOHF, and LOHF has a poor prognosis, particularly when it is complicated by infection. Systemic infection by Staphylococcus aureus resulted in a skin rash and septic pulmonary embolism, and is an absolute contraindication for liver transplantation (LT). In this treatment network, hepatologists and a transplant surgeon cooperated to overcome severe infection and their efforts led to successful transplantation. On-line hemodiafiltration is an indispensable treatment option for acute liver failure. Infection control is crucial for LT and an intensive medical care network led to successful living-donor LT.
Literature
1.
go back to reference Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5:104–15.CrossRef Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5:104–15.CrossRef
2.
go back to reference Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.CrossRefPubMed Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.CrossRefPubMed
3.
go back to reference Lee WM, Stravitz RT, Larson AM. Introduction to the revised American association for the study of liver diseases position paper on acute liver failure 2011. Hepatology. 2012;55:965–7.CrossRefPubMedPubMedCentral Lee WM, Stravitz RT, Larson AM. Introduction to the revised American association for the study of liver diseases position paper on acute liver failure 2011. Hepatology. 2012;55:965–7.CrossRefPubMedPubMedCentral
4.
5.
go back to reference Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefPubMed Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999;31:929–38.CrossRefPubMed
6.
go back to reference Kessler WR, Cummings OW, Eckert G, et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004;2:625–31.CrossRefPubMed Kessler WR, Cummings OW, Eckert G, et al. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol. 2004;2:625–31.CrossRefPubMed
7.
go back to reference Yoshiba M, Sekiyama K, Inoue K, et al. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study. J Gastroenterol. 2002;37:916–21.CrossRefPubMed Yoshiba M, Sekiyama K, Inoue K, et al. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study. J Gastroenterol. 2002;37:916–21.CrossRefPubMed
9.
go back to reference Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology. 2007;46:1138–45.CrossRefPubMed Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology. 2007;46:1138–45.CrossRefPubMed
10.
go back to reference Ichai P, Duclos-Vallee JC, Guettier C, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl. 2007;13:996–1003.CrossRefPubMed Ichai P, Duclos-Vallee JC, Guettier C, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl. 2007;13:996–1003.CrossRefPubMed
11.
go back to reference McCormack MG, Smith AJ, Akram AN, et al. Staphylococcus aureus and the oral cavity: an overlooked source of carriage and infection? Am J Infect Control. 2015;43:35–7.CrossRefPubMed McCormack MG, Smith AJ, Akram AN, et al. Staphylococcus aureus and the oral cavity: an overlooked source of carriage and infection? Am J Infect Control. 2015;43:35–7.CrossRefPubMed
14.
go back to reference Katz S, Jimenez MA, Lehmkuhler WE, et al. Liver bacterial clearance following hepatic artery ligation and portacaval shunt. J Surg Res. 1991;51:267–70.CrossRefPubMed Katz S, Jimenez MA, Lehmkuhler WE, et al. Liver bacterial clearance following hepatic artery ligation and portacaval shunt. J Surg Res. 1991;51:267–70.CrossRefPubMed
15.
go back to reference Eguchi Y, Sugimoto H. Septicaemia. Jpn J Acute Med. 2003;27:576–7. Eguchi Y, Sugimoto H. Septicaemia. Jpn J Acute Med. 2003;27:576–7.
16.
go back to reference Cook RJ, Ashton RW, Aughenbaugh GL, et al. Septic pulmonary embolism: presenting features and clinical course of 14 patients. Chest. 2005;128:162–6.CrossRefPubMed Cook RJ, Ashton RW, Aughenbaugh GL, et al. Septic pulmonary embolism: presenting features and clinical course of 14 patients. Chest. 2005;128:162–6.CrossRefPubMed
17.
go back to reference Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075–128.CrossRefPubMed
18.
go back to reference Murray RJ. Staphylococcus aureus infective endocarditis: diagnosis and management guidelines. Intern Med J. 2005;35:25–44.CrossRef Murray RJ. Staphylococcus aureus infective endocarditis: diagnosis and management guidelines. Intern Med J. 2005;35:25–44.CrossRef
19.
go back to reference Abid Q, Price D, Stewart MJ, et al. Septic pulmonary emboli caused by a hemodialysis catheter. Asian Cardiovasc Thorac Ann. 2002;10:251–3.CrossRefPubMed Abid Q, Price D, Stewart MJ, et al. Septic pulmonary emboli caused by a hemodialysis catheter. Asian Cardiovasc Thorac Ann. 2002;10:251–3.CrossRefPubMed
20.
go back to reference Ye R, Zhao L, Wang C, et al. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. Respir Med. 2014;108:1–8.CrossRefPubMed Ye R, Zhao L, Wang C, et al. Clinical characteristics of septic pulmonary embolism in adults: a systematic review. Respir Med. 2014;108:1–8.CrossRefPubMed
21.
go back to reference MacMillan JC, Milstein SH, Samson PC. Clinical spectrum of septic pulmonary embolism and infarction. J Thorac Cardiovasc Surg. 1977;75:670–9. MacMillan JC, Milstein SH, Samson PC. Clinical spectrum of septic pulmonary embolism and infarction. J Thorac Cardiovasc Surg. 1977;75:670–9.
22.
go back to reference Takeda K, Tanaka K, Kumamoto T, et al. Septic pulmonary embolism originated from subcutaneous abscess after living donor liver transplantation: a pitfall of postoperative management. Clin J Gastroenterol. 2013;6:378–82.CrossRefPubMedPubMedCentral Takeda K, Tanaka K, Kumamoto T, et al. Septic pulmonary embolism originated from subcutaneous abscess after living donor liver transplantation: a pitfall of postoperative management. Clin J Gastroenterol. 2013;6:378–82.CrossRefPubMedPubMedCentral
Metadata
Title
An intensive medical care network led to successful living-donor liver transplantation in late-onset hepatic failure with disseminated Staphylococcus aureus infection
Publication date
01-04-2019
Published in
Clinical Journal of Gastroenterology / Issue 2/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-018-0904-y

Other articles of this Issue 2/2019

Clinical Journal of Gastroenterology 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.